Thomas M. Jacks

1.3k total citations
35 papers, 1.0k citations indexed

About

Thomas M. Jacks is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, Thomas M. Jacks has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Thomas M. Jacks's work include Growth Hormone and Insulin-like Growth Factors (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Lipid metabolism and disorders (5 papers). Thomas M. Jacks is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Lipid metabolism and disorders (5 papers). Thomas M. Jacks collaborates with scholars based in United States, Germany and Japan. Thomas M. Jacks's co-authors include Bo Wu, Gerard J. Hickey, Arthur A. Patchett, Olga M. Viquez, Elaine T. Champagne, Samuel J. Landry, Hortense Dodo, Soheila J. Maleki, Si‐Yin Chung and R G Smith and has published in prestigious journals such as Water Resources Research, Journal of Bacteriology and Endocrinology.

In The Last Decade

Thomas M. Jacks

35 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Jacks United States 16 315 233 176 153 146 35 1.0k
Sonia Morales Spain 18 92 0.3× 62 0.3× 406 2.3× 143 0.9× 81 0.6× 37 1.1k
Takahiro Nagatake Japan 20 34 0.1× 17 0.1× 415 2.4× 233 1.5× 58 0.4× 52 1.3k
Martı́n Rumbo Argentina 17 29 0.1× 27 0.1× 597 3.4× 165 1.1× 72 0.5× 61 1.4k
James A. Hardin Canada 18 59 0.2× 18 0.1× 248 1.4× 86 0.6× 14 0.1× 39 840
Julian R. Pleasants United States 20 36 0.1× 18 0.1× 413 2.3× 168 1.1× 19 0.1× 43 1.2k
Sofia Tedelind Sweden 9 110 0.3× 8 0.0× 596 3.4× 224 1.5× 24 0.2× 9 972
Aneta Rogoz United States 5 44 0.1× 57 0.2× 368 2.1× 147 1.0× 3 0.0× 6 814
J Roth United States 15 50 0.2× 8 0.0× 166 0.9× 45 0.3× 46 0.3× 19 762
Laurel Doghramji United States 23 21 0.1× 51 0.2× 308 1.8× 384 2.5× 306 2.1× 33 2.3k
David Prescott Canada 14 22 0.1× 14 0.1× 445 2.5× 133 0.9× 13 0.1× 21 811

Countries citing papers authored by Thomas M. Jacks

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Jacks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Jacks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Jacks more than expected).

Fields of papers citing papers by Thomas M. Jacks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Jacks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Jacks. The network helps show where Thomas M. Jacks may publish in the future.

Co-authorship network of co-authors of Thomas M. Jacks

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Jacks. A scholar is included among the top collaborators of Thomas M. Jacks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Jacks. Thomas M. Jacks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2007). Highly potent growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 17(13). 3657–3659. 8 indexed citations
2.
Strowski, Mathias Z., Doreen E. Cashen, Elizabeth T. Birzin, et al.. (2006). Antidiabetic Activity of a Highly Potent and Selective Nonpeptide Somatostatin Receptor Subtype-2 Agonist. Endocrinology. 147(10). 4664–4673. 19 indexed citations
3.
Lu, Zhijian, James R. Tata, Kang Cheng, et al.. (2003). Substituted bridged phenyl piperidines: orally active growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 13(10). 1817–1820. 5 indexed citations
4.
Maleki, Soheila J., Olga M. Viquez, Thomas M. Jacks, et al.. (2003). The major peanut allergen, Ara h 2, functions as a trypsin inhibitor, and roasting enhances this function. Journal of Allergy and Clinical Immunology. 112(1). 190–195. 161 indexed citations
5.
Chen, Meng‐Hsin, Arthur A. Patchett, Kang Cheng, et al.. (1999). Synthesis and biological activities of spiroheterocyclic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 9(9). 1261–1266. 28 indexed citations
6.
Schleim, Klaus D., Thomas M. Jacks, Patrick N. Cunningham, et al.. (1999). Increases in Circulating Insulin-Like Growth Factor I Levels by the Oral Growth Hormone Secretagogue MK-0677 in the Beagle Are Dependent upon Pituitary Mediation1. Endocrinology. 140(4). 1552–1558. 26 indexed citations
7.
Barakat, Khaled J., Wanda Chan, Thomas M. Jacks, et al.. (1998). Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues. Bioorganic & Medicinal Chemistry Letters. 8(11). 1431–1436. 15 indexed citations
8.
Hickey, Gerard J., Thomas M. Jacks, Klaus D. Schleim, et al.. (1997). Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles. Journal of Endocrinology. 152(2). 183–192. 38 indexed citations
9.
Lieber, Richard L., Thomas M. Jacks, Klaus D. Schleim, et al.. (1997). Growth hormone secretagogue increases muscle strength during remobilization after canine hindlimb immobilization. Journal of Orthopaedic Research®. 15(4). 519–527. 21 indexed citations
10.
Jacks, Thomas M., R G Smith, Klaus D. Schleim, et al.. (1996). MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.. Endocrinology. 137(12). 5284–5289. 35 indexed citations
11.
Hickey, Gerard J., Thomas M. Jacks, R. Leonard, et al.. (1996). Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland.. PubMed. 51. 261–85; discussion 285. 94 indexed citations
12.
Nargund, Ravi P., Meng‐Hsin Chen, David B. Johnston, et al.. (1996). Peptidomimetic growth hormone secretagogues: synthesis and biological activities of analogs varied at the indole nucleus of the prototypical spiropiperidine L-162,752. Bioorganic & Medicinal Chemistry Letters. 6(14). 1731–1736. 8 indexed citations
13.
Reddy, Michael S., et al.. (1995). Alendronate Treatment of Naturally‐Occurring Periodontitis in Beagle Dogs. Journal of Periodontology. 66(3). 211–217. 117 indexed citations
14.
15.
Hickey, Gerard J., Thomas M. Jacks, J.E. Taylor, et al.. (1994). Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.. Endocrinology. 134(2). 695–701. 49 indexed citations
16.
Jacks, Thomas M., et al.. (1988). Effect of efrotomycin in feed on the quantity, duration, and prevalence of shedding and antibacterial susceptibility of Salmonella typhimurium in experimentally infected swine. American Journal of Veterinary Research. 49(11). 1832–1835. 13 indexed citations
17.
Jacks, Thomas M., et al.. (1986). 3-Acetyl-4″-isovaleryl tylosin for prevention of swine dysentery. American Journal of Veterinary Research. 47(11). 2325–2328. 2 indexed citations
18.
Jacks, Thomas M., et al.. (1981). Cephamycin C treatment of induced swine salmonellosis. Antimicrobial Agents and Chemotherapy. 19(4). 562–566. 2 indexed citations
19.
Jacks, Thomas M. & Bo Wu. (1974). Biochemical Properties of Escherichia coli Low-Molecular-Weight, Heat-Stable Enterotoxin. Infection and Immunity. 9(2). 342–347. 86 indexed citations
20.
Jacks, Thomas M., et al.. (1968). An Evaluation of the Use of Escherichia Coli Serogroups as a Means of Tracing Microbial Pollution in Water. Water Resources Research. 4(3). 625–638. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Morales Breakdown of academic impact, for papers by Takahiro Nagatake Breakdown of academic impact, for papers by Martı́n Rumbo Breakdown of academic impact, for papers by James A. Hardin Breakdown of academic impact, for papers by Julian R. Pleasants Breakdown of academic impact, for papers by Sofia Tedelind Breakdown of academic impact, for papers by Aneta Rogoz Breakdown of academic impact, for papers by J Roth Breakdown of academic impact, for papers by Laurel Doghramji Breakdown of academic impact, for papers by David Prescott
Rankless by CCL
2026